Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis through histone acetylation and upregulation of annexin A1 in AML1-ETO expressing kasumi-1 cells.

被引：0
|
作者：
Tabe, Y
Contractor, R
Radke, S
Andreeff, M
Konopleva, M
机构：
[1] Univ Texas, MD Anderson Cancer Ctr, Houston, TX USA
[2] Juntendo Univ Med, Tokyo, Japan
[3] Mt Sinai Sch Med, New York, NY USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4343
引用
收藏
页码：170B / 170B
页数：1
相关论文
共 50 条
  • [21] Establishment of AML1-ETO positive acute myelocytic leukemia animal model through inoculation of Kasumi-1 cells intravenously or intraperitoneally into immunodeficiency mice.
    Zhou, GB
    Dong, Y
    Zhang, L
    Jin, XL
    Tong, JH
    Wang, ZG
    Wang, ZY
    Chen, Z
    Chen, SJ
    BLOOD, 2003, 102 (11) : 181B - 181B
  • [22] Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity
    Lee, YM
    Kim, SH
    Kim, HS
    Son, MJ
    Nakajima, H
    Kwon, HJ
    Kim, KW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (01) : 241 - 246
  • [23] Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1
    D'Acunto, Cosimo Walter
    Fontanella, Bianca
    Rodriquez, Manuela
    Taddei, Maurizio
    Parente, Luca
    Petrella, Antonello
    CANCER LETTERS, 2010, 295 (01) : 85 - 91
  • [24] Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1
    Y Tabe
    L Jin
    R Contractor
    D Gold
    P Ruvolo
    S Radke
    Y Xu
    Y Tsutusmi-Ishii
    K Miyake
    N Miyake
    S Kondo
    A Ohsaka
    I Nagaoka
    M Andreeff
    M Konopleva
    Cell Death & Differentiation, 2007, 14 : 1443 - 1456
  • [25] Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1
    Tabe, Y.
    Jin, L.
    Contractor, R.
    Gold, D.
    Ruvolo, P.
    Radke, S.
    Xu, Y.
    Tsutusmi-Ishii, Y.
    Miyake, K.
    Miyake, N.
    Kondo, S.
    Ohsaka, A.
    Nagaoka, I.
    Andreeff, M.
    Konopleva, M.
    CELL DEATH AND DIFFERENTIATION, 2007, 14 (08): : 1443 - 1456
  • [26] The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21
    Son, Deok-Soo
    Wilson, Andrew J.
    Parl, Angelika K.
    Khabele, Dineo
    CANCER BIOLOGY & THERAPY, 2010, 9 (11) : 928 - 935
  • [27] Repression of the human lysozyme gene in AML1/ETO expressing myeloid cells is relieved by histone deacetylase inhibition.
    Claus, R
    Fliegauf, M
    Lübbert, M
    BLOOD, 2000, 96 (11) : 131B - 131B
  • [28] Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21Waf1/Cip1
    Zhao, Y
    Lu, SL
    Wu, LP
    Chai, GL
    Wang, HY
    Chen, YQ
    Sun, J
    Yu, Y
    Zhou, W
    Zheng, QH
    Wu, M
    Otterson, GA
    Zhu, WG
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (07) : 2782 - 2790
  • [29] The histone deacetylase inhibitor depsipeptide (FR901228) induces apoptosis via activation of the caspase 8 pathway concurrent with lysine specific acetylation in chronic lymphocytic leukemia cells.
    Aron, JL
    Murphy, T
    Parthun, MR
    Bannerji, R
    Kanakry, C
    Lucas, D
    Flinn, IW
    Marcucci, G
    Grever, MR
    Byrd, JC
    BLOOD, 2001, 98 (11) : 807A - 808A
  • [30] Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells
    Klisovic, MI
    Maghraby, EA
    Parthun, MR
    Guimond, M
    Sklenar, AR
    Whitman, SP
    Chan, KK
    Murphy, T
    Anon, J
    Archer, KJ
    Rush, LJ
    Plass, C
    Grever, MR
    Byrd, JC
    Marcucci, G
    LEUKEMIA, 2003, 17 (02) : 350 - 358
12345